In contrast to the persistent presence of IDH1 mutations throughout tumour progression, p16/CDKN2A copy number variation only occurred in high grade chondrosarcomas (GII, GIII or dedifferentiated neoplasms). This evidence concerns the gene CDKN2A and neoplasm.